Leadiant Biosciences Limited
Records under this name other than the patents Leadiant Biosciences Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Leadiant Biosciences Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,071,741 | Stable recombinant adenosine deaminase Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,741,283 | Adenosine deaminase anticancer therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,391,154 | Compositions and Methods for Treating or Ameliorating Fibrosis, Systemic Sclerosis and Scleroderma Formerly held In force · High confidence | In force | High confidence | |
| US 7,333,894 | Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients Term ended Term ended Nov 26, 2024 · From the USPTO record | Term ended | Term ended Nov 26, 2024 | From the USPTO record |
| US 7,011,977 | Quantification of carnitine levels in dialysis patients Term ended Term ended Oct 3, 2019 · From the USPTO record | Term ended | Term ended Oct 3, 2019 | From the USPTO record |
| US 6,406,713 | Methods of preparing low-toxicity drug-lipid complexes Term ended Term ended Jun 18, 2019 · From the USPTO record | Term ended | Term ended Jun 18, 2019 | From the USPTO record |
| US 4,973,465 | Microcrystals comprising an active substance having an affinity for phospholipids, and at least one phospholipid, process of preparation Term ended Term ended no later than Nov 27, 2010 · Low confidence | Term ended | Term ended no later than Nov 27, 2010 | Low confidence |
| US 5,100,591 | Process for preparing lipid microparticles Term ended Term ended no later than Mar 31, 2012 · Low confidence | Term ended | Term ended no later than Mar 31, 2012 | Low confidence |
| US 5,616,334 | Low toxicity drug-lipid systems Term ended Term ended no later than Apr 1, 2017 · Low confidence | Term ended | Term ended no later than Apr 1, 2017 | Low confidence |
| US 5,728,560 | Method of treating CD4+ T cell lymphopenia in immuno-compromised patients Term ended Term ended no later than Mar 17, 2018 · Low confidence | Term ended | Term ended no later than Mar 17, 2018 | Low confidence |